Original Articles

The economics, financing and implementation of HIV treatment as prevention: What will it take to get there?

DOI: 10.2989/16085906.2014.943254
Author(s): David WilsonThe World Bank Group, USA, Jessica TaaffeThe World Bank Group, USA, Nicole Fraser-HurtThe World Bank Group, USA, Marelize GorgensThe World Bank Group, USA


The 2013 Lancet Commission Report, Global Health 2035, rightly pointed out that we are at a unique place in history where a “grand convergence” of health initiatives to reduce both infectious diseases, and child and maternal mortality – diseases that still plague low income countries – would yield good returns in terms of development and health outcomes. This would also be a good economic investment. Such investments would support achieving health goals of reducing under-five (U5) mortality to 16 per 1 000 live births, reducing deaths due to HIV/AIDS to 8 per 100 000 population, and reducing annual TB deaths to 4 per 100 000 population.

Get new issue alerts for African Journal of AIDS Research